Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus Paclitaxel/Carboplatin/Bevacizumab in untreated advanced pulmonary adenocarcinoma
NCT01578551Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- May 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of metformin in lung adenocarcinoma, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started May 2012; status: terminated.
02
Drugs
metformin
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT01578551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01578551.